Burgess Sonya N, Mamas Mamas A
Department of Cardiology, Nepean Hospital, Sydney, Australia.
University of Sydney, NSW, Australia.
Am Heart J Plus. 2022 Nov 5;24:100225. doi: 10.1016/j.ahjo.2022.100225. eCollection 2022 Dec.
This review evaluates published data regarding outcomes for women with ACS undergoing PCI. Data is discussed from a patient centred perspective and timeline, beginning with sex-based differences in perception of risk, time to presentation, time to treatment, access to angiography, access to angioplasty, the impact of incomplete revascularization, prescribing practices, under-representation of women in randomized controlled trials and in cardiology physician workforces. The objective of the review is to identify factors contributing to outcome disparities for women with ACS, and to discuss potential solutions to close this outcome gap.
本综述评估了已发表的关于接受经皮冠状动脉介入治疗（PCI）的急性冠状动脉综合征（ACS）女性患者预后的数据。从以患者为中心的角度和时间线来讨论数据，内容包括基于性别的风险认知差异、就诊时间、治疗时间、血管造影检查的可及性、血管成形术的可及性、不完全血运重建的影响、处方习惯、女性在随机对照试验和心脏病学医师队伍中的代表性不足等方面。该综述的目的是确定导致ACS女性患者预后差异的因素，并讨论缩小这一预后差距的潜在解决方案。
